p27 and Metastatic Progression: Molecular Mechanisms Underlying Bone Metastasis
The complex PI3K/mTOR pathway regulates tumor progression via effects on cellular proliferation, apoptosis, autophagy, and motility. New drugs that inhibit the catalytic site of both PI3K and mTOR have shown promise in clinical trials. Here, we report the first use of a novel, dual PI3K/mTOR catalyt...
Main Author: | Wander, Seth A |
---|---|
Format: | Others |
Published: |
Scholarly Repository
2011
|
Subjects: | |
Online Access: | http://scholarlyrepository.miami.edu/oa_dissertations/690 |
Similar Items
-
Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells
by: Tang S, et al.
Published: (2019-01-01) -
Transfer of metastatic traits via miR‐200c in extracellular vesicles derived from colorectal cancer stem cells is inhibited by atractylenolide I
by: Dongxin Tang, et al.
Published: (2020-08-01) -
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
by: Charles N. Landen, et al.
Published: (2013-04-01) -
mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01) -
Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway
by: Xia E, et al.
Published: (2018-06-01)